AAAAAA

   
Results: 1-22 |
Results: 22
CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING
Authors: CHAN KK ZHANG Z CHEN H GANAPATHI R HAYTON W ELSON P HAWK E KELLOFF G BUDD GT
Citation: Kk. Chan et al., CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING, Annals of oncology, 9, 1998, pp. 476-476
INTEROBSERVER REPRODUCIBILITY (IR) OF THE LAGIOS NUCLEAR GRADING SYSTEM FOR DUCTAL CARCINOMA IN-SITU (DCIS)
Authors: SNEIGE N LAGIOS M SCHWARTING R COLBURN W ATKINSON E WEBER D RISIN S SAHIN A KEMP B BOONE C DHINGRA K KELLOFF G LIPPMAN S
Citation: N. Sneige et al., INTEROBSERVER REPRODUCIBILITY (IR) OF THE LAGIOS NUCLEAR GRADING SYSTEM FOR DUCTAL CARCINOMA IN-SITU (DCIS), Modern pathology, 11(1), 1998, pp. 28-28
QUANTITATIVE METHODS IN PROSTATE PATHOLOGY - RECENT FINDINGS AND FUTURE-DIRECTIONS - FOREWORD
Authors: KELLOFF G BOONE C
Citation: G. Kelloff et C. Boone, QUANTITATIVE METHODS IN PROSTATE PATHOLOGY - RECENT FINDINGS AND FUTURE-DIRECTIONS - FOREWORD, Analytical and quantitative cytology and histology, 20(5), 1998, pp. 322-322
INTEROBSERVER REPRODUCIBILITY (IR) OF THE LAGIOS NUCLEAR GRADING SYSTEM FOR DUCTAL CARCINOMA IN-SITU (DCIS)
Authors: SNEIGE N LAGIOS M SCHWERTING R COLBURN W ATKINSON E WEBER D RISIN S SAHIN A KEMP B BOONE C DHINGRA K KELLOFF G LIPPMAN S
Citation: N. Sneige et al., INTEROBSERVER REPRODUCIBILITY (IR) OF THE LAGIOS NUCLEAR GRADING SYSTEM FOR DUCTAL CARCINOMA IN-SITU (DCIS), Laboratory investigation, 78(1), 1998, pp. 145-145
EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS
Authors: VANSTOLK R BUDD GT KRESTY R GANAPATHI R ELSON P CHURCH J PIAZZA G FRYER B PROVENCHER K PAMUKCU R HAWK E KELLOFF G STONER G
Citation: R. Vanstolk et al., EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS, Gastroenterology, 114(4), 1998, pp. 2881-2881
SUPPRESSION OF HUMAN COLORECTAL MUCOSAL PROSTAGLANDINS - DETERMINING THE LOWEST EFFECTIVE ASPIRIN DOSE
Authors: RUFFIN MT KRISHNAN K ROCK CL NORMOLLE D VAERTEN MA PETERSGOLDEN M CROWELL J KELLOFF G BOLAND CR BRENNER DE
Citation: Mt. Ruffin et al., SUPPRESSION OF HUMAN COLORECTAL MUCOSAL PROSTAGLANDINS - DETERMINING THE LOWEST EFFECTIVE ASPIRIN DOSE, Journal of the National Cancer Institute, 89(15), 1997, pp. 1152-1160
SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM
Authors: PIAZZA GA FRYER BH VANSTOLK RU BUDD GT STONER GD HAWK E KELLOFF G PAMUKCU R AHNEN DJ GANAPATHI R
Citation: Ga. Piazza et al., SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM, Gastroenterology, 112(4), 1997, pp. 638-638
PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY
Authors: VANSTOLK RU BUDD GT HAYTON W ELSON P PROVENCHER K CHURCH JM GANAPATHI R STONER G HAWK E PAMUKCU R KELLOFF G CHAN K
Citation: Ru. Vanstolk et al., PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY, Gastroenterology, 112(4), 1997, pp. 673-673
CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/
Authors: VANSTOLK RU DEYOUNG B CHURCH JM GANAPATHI R PROVENCHER K STONER G HAWK E PAMUKCU R KELLOFF G BUDD GT
Citation: Ru. Vanstolk et al., CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/, Gastroenterology, 112(4), 1997, pp. 673-673
SURROGATE END-POINT BIOMARKER (SEB) GUIDED DRUG DEVELOPMENT - A PRACTICAL STRATEGY FOR CHEMOPREVENTION (CP) OF PREINVASIVE CANCER (PRECA)
Authors: LIEBERMAN R BOONE C CROWELL J HAWK E MALONE W STEELE V LUBET R SIGMAN C KELLOFF G
Citation: R. Lieberman et al., SURROGATE END-POINT BIOMARKER (SEB) GUIDED DRUG DEVELOPMENT - A PRACTICAL STRATEGY FOR CHEMOPREVENTION (CP) OF PREINVASIVE CANCER (PRECA), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 1-1
ENHANCEMENT OF EXPERIMENTAL COLON-CANCER BY GENISTEIN
Authors: RAO CV WANG CX SIMI B LUBET R KELLOFF G STEELE V REDDY BS
Citation: Cv. Rao et al., ENHANCEMENT OF EXPERIMENTAL COLON-CANCER BY GENISTEIN, Cancer research, 57(17), 1997, pp. 3717-3722
NSAID TRIALS, SPORADIC ADENOMAS, AND CONSERVATIVE INFERENCES
Authors: HAWK E PRINDIVILLE S KELLOFF G
Citation: E. Hawk et al., NSAID TRIALS, SPORADIC ADENOMAS, AND CONSERVATIVE INFERENCES, Gastroenterology, 110(2), 1996, pp. 654-654
CHEMOPREVENTIVE EFFICACY OF ARYLALKYL ISOTHIOCYANATES AND N-ACETYLCYSTEINE FOR LUNG TUMORIGENESIS IN FISCHER RATS
Authors: CHUNG FL KELLOFF G STEELE V PITTMAN B ZANG E JIAO D RIGOTTY J CHOI CI RIVENSON A
Citation: Fl. Chung et al., CHEMOPREVENTIVE EFFICACY OF ARYLALKYL ISOTHIOCYANATES AND N-ACETYLCYSTEINE FOR LUNG TUMORIGENESIS IN FISCHER RATS, Cancer research, 56(4), 1996, pp. 772-778
INHIBITION OF NO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE-INDUCED LYMPHOMA FORMATION BY OLTIPRAZ
Authors: RAO CV RIVENSON A ZANG E STEELE V KELLOFF G REDDY BS
Citation: Cv. Rao et al., INHIBITION OF NO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE-INDUCED LYMPHOMA FORMATION BY OLTIPRAZ, Cancer research, 56(15), 1996, pp. 3395-3398
CHEMOPREVENTION AND DIETARY PREVENTION OF COLORECTAL-CANCER
Authors: SCHATZKIN A KELLOFF G
Citation: A. Schatzkin et G. Kelloff, CHEMOPREVENTION AND DIETARY PREVENTION OF COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1198-1204
INHIBITION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO-[4,5-B]PYRIDINE (PHIP)-INDUCED LYMPHOMA BY OLTIPRAZ IN RATS
Authors: RIVENSON A RAO CV STEELE V KELLOFF G REDDY BS
Citation: A. Rivenson et al., INHIBITION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO-[4,5-B]PYRIDINE (PHIP)-INDUCED LYMPHOMA BY OLTIPRAZ IN RATS, The FASEB journal, 9(3), 1995, pp. 139-139
CHEMOPREVENTION OF COLON CARCINOGENESIS BY SULINDAC, A NONSTEROIDAL ANTIINFLAMMATORY AGENT
Authors: RAO CV RIVENSON A SIMI B ZANG E KELLOFF G STEELE V REDDY BS
Citation: Cv. Rao et al., CHEMOPREVENTION OF COLON CARCINOGENESIS BY SULINDAC, A NONSTEROIDAL ANTIINFLAMMATORY AGENT, Cancer research, 55(7), 1995, pp. 1464-1472
CHEMOPREVENTION
Authors: GREENWALD P KELLOFF G BURCHWHITMAN C KRAMER BS
Citation: P. Greenwald et al., CHEMOPREVENTION, Ca, 45(1), 1995, pp. 31
MODULATION OF AZOXYMETHANE-INDUCED MUTATIONAL ACTIVATION OF RAS PROTOONCOGENES BY CHEMOPREVENTIVE AGENTS IN COLON CARCINOGENESIS
Authors: SINGH J KULKARNI N KELLOFF G REDDY BS
Citation: J. Singh et al., MODULATION OF AZOXYMETHANE-INDUCED MUTATIONAL ACTIVATION OF RAS PROTOONCOGENES BY CHEMOPREVENTIVE AGENTS IN COLON CARCINOGENESIS, Carcinogenesis, 15(7), 1994, pp. 1317-1323
INHIBITORY EFFECT OF ASPIRIN ON AZOXYMETHANE-INDUCED COLON CARCINOGENESIS IN F344 RATS
Authors: REDDY BS RAO CV RIVENSON A KELLOFF G
Citation: Bs. Reddy et al., INHIBITORY EFFECT OF ASPIRIN ON AZOXYMETHANE-INDUCED COLON CARCINOGENESIS IN F344 RATS, Carcinogenesis, 14(8), 1993, pp. 1493-1497
RESEARCH STUDIES ON CHEMOPREVENTION OF ESOPHAGEAL CANCER AT THE UNITED-STATES NATIONAL-CANCER-INSTITUTE
Authors: GREENWALD P KELLOFF G KALAGHER S MCDONALD S
Citation: P. Greenwald et al., RESEARCH STUDIES ON CHEMOPREVENTION OF ESOPHAGEAL CANCER AT THE UNITED-STATES NATIONAL-CANCER-INSTITUTE, Endoscopy, 25(9), 1993, pp. 617-626
CHEMOPREVENTION OF COLON CARCINOGENESIS BY ORGANOSULFUR COMPOUNDS
Authors: REDDY BS RAO CV RIVENSON A KELLOFF G
Citation: Bs. Reddy et al., CHEMOPREVENTION OF COLON CARCINOGENESIS BY ORGANOSULFUR COMPOUNDS, Cancer research, 53(15), 1993, pp. 3493-3498
Risultati: 1-22 |